STARHEALTHFinancial Services

Star Health and Allied Insurance Company Limited

General Insurance · ISIN INE575P01011 · BSE 543412 · NSE EQ · FV ₹10
Last price
₹531
+1.52%today
What this company does

Star Health and Allied Insurance Company Limited operates in General Insurance, part of the Financial Services sector. It is the largest of 1 General Insurance companies we track, by market value.

Their stated vision

“To be the most admired health insurance company in India.”

In the report:
47out of 100
Equitytale Health Score
Mixed

Healthier than 47% of companies in Financial Services, on the 3 of 6 measures we could read for it. Each measure is ranked against the 192–253 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
42

At close. Not part of the score.

Profitability & returns39

How much profit it earns on the money it employs

Valuation21

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Not measurable for this company: balance sheet, cash quality, growth & consistency. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
Looks broadly healthy
Strengths
✓ Makes a profit
✓ Promoters hold 58%
✓ No promoter shares pledged
✓ Virtually debt-free
✓ Turns profit into real cash
Watch-outs
None flagged from our data

What if I invest in STARHEALTH?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹531▲ +1.52%
latest close · 2026-11-04
52-wk low ₹495212 sessions so far52-wk high ₹940
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio29.5Average
LowAverageHigh
P/B ratio2.99Moderate
Below bookModerateHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity10.2%Fair
WeakFairStrong ▸15%
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.01Comfortable
LowModerateHigh ▸1
More figures
Market cap
₹31,218 cr
Book value
₹177
EPS
₹4.50
latest quarter
Net debt
—
Enterprise value
—
EBITDA
—
EBIT
—
Operating margin
—
Return on assets
4.4%
Earnings yield
3.39%
P/S
—
Sales / share
—
Tax rate
—
Face value
₹10
Shares
58.8 cr
Working capital
—
Current assets
—
Current liabilities
—
Delivery %
58.6%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-11-04.

Worth vs price · from the FY 2025 report & filings
not investment advice
Hard to value confidentlyLow confidence
We haven't parsed this company's annual profit history yet — common for banks and insurers, whose results file in a different format — so we can't value it off earnings.
Models span ₹136–₹136, midpoint ₹136

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q2 FY27 (consolidated)
Other Income₹6 cr
Other Expenses₹290 cr
Net Profit₹265 cr
Where the money goes

Not enough income-statement detail filed to break this down yet.

Quarterly results · consolidated (₹ cr)
MetricQ4 FY26Q1 FY27Q2 FY27
Revenue———
Total income———
Expenses———
Profit before tax———
Tax———
Net profit (owners' share)—550 cr265 cr
Net margin (owners' share, on revenue)———
EPS (₹)—9.344.50
Balance sheet & cash flow · as of Sep 2026
Debt-free
Total assets
₹24,293 cr
Shareholder equity
₹10,436 cr
parent shareholders
Total debt
₹76 cr
Cash
₹338 cr
Cash flow · H1 FY27
Operating
₹611 cr
Investing
₹-630 cr
Financing
₹-464 cr
Peer comparison
General Insurance · by market value
CompanyPriceMarket capP/E
Star Health and Allied Insurance Company Limitedthis company₹523₹30,750 cr29.0
General Insurance Corporation of India₹319——
The New India Assurance Company Limited₹156——
Niva Bupa Health Insurance Company Limited₹73——
Go Digit General Insurance Limited₹253——
ICICI Lombard General Insurance Company Limited₹1,595——
Same industry · latest reported numbers · not a recommendation.
Who owns it · 2026-09-30
No pledge
Promoter
58.0%
FII / Foreign
15.8%
DII / Domestic
18.8%
Retail / others
7.4%
Promoter stake up 0.1% over the last 12 quarters.
Smart-money activity
Insider trades
BoughtSETU AIF TRUST · Promoter Group1.77 L · ₹8.4 cr3 Jun 25
BoughtSETU AIF TRUST · Promoter Group67,000 · ₹3.2 cr2 Jun 25
BoughtSETU AIF TRUST · Promoter Group2.90 L · ₹13.8 cr2 Jun 25
Bulk / block deals
short— · NSE5221 Oct 26
short— · NSE20025 Sep 26
BoughtSBI MUTUAL FUND · NSE82.99 L @ ₹550.424 Sep 26
Stake changes
SoldEstate of Late Mr. Rakesh Jhunjhunwala · promoter→ 0.00% · 7.68 cr25 Jun 26
BoughtSitara Partners LLP · promoter→ 13.29% · 7.82 cr24 Jun 26
BoughtSitara Partners LLP · promoter→ 13.29% · 7.82 cr24 Jun 26
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 28 Aug 2026
See the official result
1
To receive, consider and adopt the audited Standalone financial statements of the Company for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and Auditors thereon.
Backed by 100% of shareholders other than promotersneeded 50%
15.75 cr votes for, 537 against · 0% of mutual funds and other big investors said no
2
To appoint a Director in place of Mr. Deepak Ramineedi (DIN: 07631768), who retires by rotation and being eligible, offers himself for re-appointment.
Backed by 99% of shareholders other than promotersneeded 50%
18.14 cr votes for, 21.66 L against · 1% of mutual funds and other big investors said no
3
To appoint Mr. Utpal Hemendra Sheth (DIN: 00081012), as a Nominee Director of the Company to represent Sitara Partners LLP.
Promoters had a personal stake in this
Backed by 93% of shareholders other than promotersneeded 75%
17.10 cr votes for, 1.25 cr against · 7% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 189 named members
owning 58.0% between them · as of 2026-09-30
SAFECROP INVESTMENTS INDIA LLP40.17%
SITARA PARTNERS LLP13.29%
REKHA JHUNJHUNWALA3.04%
UTPAL H SHETH0.55%
SETU AIF TRUST0.36%
SANDEEP SINGHAL0.29%
AMIT GOELA0.25%
USHMA SHETH SULE0.05%

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.